Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Approval Registry: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain

NCT01834937 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT01834937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01834937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Approval Registry: ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain
Lead sponsor
InSightec
Phase
Observational
Overall status
Terminated
Start date
June 30, 2013
Completion date
April 30, 2017
Enrollment
17 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pain resulting from bone metastases